<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04678349</url>
  </required_header>
  <id_info>
    <org_study_id>NMRR-19-3119-51323</org_study_id>
    <nct_id>NCT04678349</nct_id>
  </id_info>
  <brief_title>The Role of Partial Hydrolyzed Guar Gum in High Stoma Output Management Among Cancer Patients With Ileostomy</brief_title>
  <official_title>The Role of Partial Hydrolyzed Guar Gum in High Stoma Output Management Among Cancer Patients With Ileostomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universiti Putra Malaysia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute, Malaysia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universiti Putra Malaysia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      this is a cross sectional intervention study to investigate the role of partial hydrolyzed&#xD;
      guar gum in high stoma output management among cancer patients with ileostomy. This study&#xD;
      hypotheses there is improvement in stoma output in PHGG if compare with control. There are&#xD;
      two groups of subjects in this study. Conventional group (CG) will include retrospective&#xD;
      historical data (those subjects with post-operative ileostomy) from Jan 2016 to June 2019.&#xD;
      Intervention group (PHGG) will be subjects with ileostomy which involves prospective&#xD;
      intervention by giving partial hydrolyzed guar gum upon start orally. Data on stoma output&#xD;
      (volume &amp; consistency), length of hospital stay, readmission within 30-days discharged and&#xD;
      dietary intake will be recorded in data collection form.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ileostomy stoma output</measure>
    <time_frame>up to 1 month</time_frame>
    <description>consistency (bristrol stool chart; range 1-7; 1 hard while 7 watery)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ileostomy stoma output</measure>
    <time_frame>up to 1 month</time_frame>
    <description>volume (ml)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Length of hospital stay</measure>
    <time_frame>up to 1 month</time_frame>
    <description>days of hospital stays</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission within 30-days discharged</measure>
    <time_frame>up to 1 month</time_frame>
    <description>readmit to ward due to complications after discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dietary intake</measure>
    <time_frame>up to 1 month</time_frame>
    <description>energy (kcal/day)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dietary intake</measure>
    <time_frame>up to 1 month</time_frame>
    <description>protein intake (g/day)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>PHGG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient who met inclusion criteria and consented during intervention period will be assigned as PHGG group. Surgical medical officer will obtain consent from eligible subject. After consented, subjects will be assessed weight and PG-SGA during admission. They will be given 4 scoops (40g) PHGG, which provide 160kcal, 0.24g protein, 30.4g soluble fibre, 40g carbohydrate and 0g sugar once allowed orally. Staff nurse in charged will monitor compliance of subject on the PHGG. Daily stoma output &amp; consistency will be recorded and daily energy protein intake will be assessed by dietitian in charged. Renal profile will be taken daily as routine procedure for patients with ileostomy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CG</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Historical records of patients with ileostomy under conventional care from January 2016 to June 2019 (before started on PHGG) will be assessed and traced retrospectively from the medical system. Data will be recorded in data collection sheet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>PHGG</intervention_name>
    <description>Subjects will be given 4 scoops (40g) PHGG, which provide 160kcal, 0.24g protein, 30.4g soluble fibre, 40g carbohydrate and 0g sugar, once allowed orally.</description>
    <arm_group_label>PHGG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>conventional care</intervention_name>
    <description>follow low fibre diet and anti-diarrhea drugs</description>
    <arm_group_label>CG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cancer patients with ileostomy&#xD;
&#xD;
          -  At least 18 years of age&#xD;
&#xD;
          -  Malaysian&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Not cancer patients with ileostomy&#xD;
&#xD;
          -  Patients who participate in other study at the same time&#xD;
&#xD;
          -  Vulnerable subjects&#xD;
&#xD;
          -  Palliative patients&#xD;
&#xD;
          -  Patient has fistula&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chiou Yi Ho</last_name>
    <phone>03-88925555</phone>
    <phone_ext>3406</phone_ext>
    <email>agneshcy0326@gmail.com</email>
  </overall_contact>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 24, 2020</study_first_submitted>
  <study_first_submitted_qc>December 16, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 21, 2020</study_first_posted>
  <last_update_submitted>April 26, 2021</last_update_submitted>
  <last_update_submitted_qc>April 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Institute, Malaysia</investigator_affiliation>
    <investigator_full_name>HO CHIOU YI</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

